Protocol Ledger

NCT05332561 · Phase II · RECRUITING

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Interventional Phase II clinical trial protocol NCT05332561 sponsored by German Cancer Research Center in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-06-29 Enrollment: 240 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05332561
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)240 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05332561
Protocol FieldVerified Registry Value
NCT IdentifierNCT05332561
Consolidated Lead SponsorGerman Cancer Research Center
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment240 participants (ESTIMATED)
Registered Start Date2023-06-29
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05332561
Hospital Research SiteLocationSite Profile
Universitätsklinikum TübingenTübingen, GermanyOpen Hospital Dossier ->
Universitätsklinikum UlmUlm, GermanyOpen Hospital Dossier ->
Charité Universitätsmedizin BerlinBerlin, GermanyOpen Hospital Dossier ->
Universitätsklinikum EssenEssen, GermanyOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI